Published June 7, 2022
Cellevate awarded € 2.48 million grant through the European Innovation Council Accelerator competitive program
Cellevate’s proprietary Cellevat3d™ Microcarriers biopharmaceuticals production program to be accelerated towards industrialization LUND, Sweden – Today Cellevate received approval for a two-year € 2.48 million grant funded through the European Innovation Council Accelerator program. The grant is dedicated to develop and scale up for the large-scale commercialization of the nanofiber-based Cellevat3d™ Microcarriers product portfolio, designed…
Published April 21, 2022
Cellevate launches new website today
LUND, Sweden – Cellevate is inviting visitors to explore its newly redesigned website www.cellevate.com. The new website has been created to provide visitors detailed, extensive and up to date information about Cellevat3d™- the single use, scalable and sustainable breakthrough nanotechnology platform and its applications, from R&D to large scale biomanufacturing. On the new website, visitors can also…
Published April 21, 2022
Cellevate appoints Laura Chirica as new CEO- mission to lead the company into large scale commercialization
LUND, Sweden – Laura Chirica has a broad and extensive experience within life science, diagnostics and biotech industry. Her insights include technology development, company and commercialization strategy, organization development, sales and marketing, business development, stock market introduction, project, and program management. Laura has been responsible for large capital projects, portfolios of products and platforms for…
